 |
|
Relationship Between Postmenopausal Hormone Replacement Therapy and Ovarian Cancer
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
To the Editor: Dr Rodriguez and colleagues1 found a direct association between the use of hormone replacement therapy (HRT) and the risk of ovarian cancer. Data from other cohort and case-control studies, however, are less consistent.2
To further explore this issue, we updated the analysis of a collaborative reanalysis of European case-control studies of ovarian cancer.3 The present analysis study included 2501 women with histologically confirmed epithelial ovarian cancer and 5882 controls enrolled in 5 case-control studies: 2 were conducted in Greece, 1 in the United Kingdom, and 1 in Italy between 1979 and 1991, all previously reported,3 plus another case-control study conducted in 4 Italian locations between 1992 and 1999.4
The 5 original datasets were combined in a uniform format that included comparable variables, such as age, socioeconomic level, parity, oral contraceptive use, menopausal status, type of menopause, age at menopause, as well as HRT use, duration of use, . . . [Full Text of this Article]
RELATED ARTICLE
Estrogen Replacement Therapy and Ovarian Cancer Mortality in a Large Prospective Study of US Women
Carmen Rodriguez, Alpa V. Patel, Eugenia E. Calle, Eric J. Jacob, and Michael J. Thun
JAMA. 2001;285(11):1460-1465.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis
Greiser et al.
Hum Reprod Update 2007;13:453-463.
ABSTRACT
| FULL TEXT
Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer
Glud et al.
Arch Intern Med 2004;164:2253-2259.
ABSTRACT
| FULL TEXT
|
